Who is sponsoring NCT04037852?

NCT04037852 is sponsored by Changhua Christian Hospital.

What drugs are being tested in NCT04037852?

Interventions in NCT04037852: robotic assisted nipple sparing mastectomy, Endoscopic assisted nipple sparing mastectomy, Conventional nipple sparing mastectomy.

What condition does NCT04037852 study?

NCT04037852 studies Breast Cancer Female.

Is NCT04037852 still recruiting?

NCT04037852 is currently status unknown. Last updated 13 September 2021.

Last reviewed 2021-09-13 · How we verify

NCT04037852: RCENSM-P

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Robotic Versus Conventional or Endoscopic Nipple Sparing Mastectomy in the Management of Breast Cancer-Prospective Study

Status unknown NA Last updated 13 September 2021

What this trial tests

NA trial testing robotic assisted nipple sparing mastectomy in Breast Cancer Female in 180 participants. Status unknown.

Timeline

1 October 2019

Primary endpoint
31 December 2021

28 February 2022

Quick facts

Lead sponsor	Changhua Christian Hospital
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	non randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	180
Start date	1 October 2019
Primary completion	31 December 2021
Estimated completion	28 February 2022
Sites	11 locations across Taiwan

Drugs / interventions tested

robotic assisted nipple sparing mastectomy
Endoscopic assisted nipple sparing mastectomy
Conventional nipple sparing mastectomy

Conditions studied

Breast Cancer Female — all drugs for Breast Cancer Female →

Sponsor

Changhua Christian Hospital

Who can join

Adults 20 to 70, female only, with Breast Cancer Female. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study will prospectively evaluate the surgical outcomes of robotic nipple sparing mastectomy (NSM) compared with endoscopic assisted NSM or conventional NSM in the management of breast cancer. One-third patients would received R-NSM, another one-third received C-NSM while the other one-third would receive E-NSM.

Publications & conference data

3 peer-reviewed publications reference this trial (live from Europe PMC):

Robotic Versus Conventional or Endoscopic-assisted Nipple-sparing Mastectomy and Immediate Prosthesis Breast Reconstruction in the Management of Breast Cancer: A Prospectively Designed Multicenter Trial Comparing Clinical Outcomes, Medical Cost, and Patient-reported Outcomes (RCE
Lai HW, Chen DR, Liu LC, Chen ST, et al · · 2024 · cited 31× · PMID 37226826 · DOI 10.1097/sla.0000000000005924
Mastectomy with Reconstruction Including Robotic Endoscopic Surgery (MARRES): a prospective cohort study of the Korea Robot-Endoscopy Minimal Access Breast Surgery Study Group (KoREa-BSG) and Korean Breast Cancer Study Group (KBCSG).
Ryu JM, Lee J, Lee J, Ko B, et al · · 2023 · cited 19× · PMID 37344780 · DOI 10.1186/s12885-023-10978-0
Consensus Statement on Robotic Nipple Sparing Mastectomy Expert Panel.
Ryu JM, Mok CW, Toesca A, Lai HW, et al · · 2025 · cited 4× · PMID 40432351 · DOI 10.4048/jbc.2025.0030

Verify or expand the search:

Other recruiting trials for Breast Cancer Female

Currently open trials in the same condition.

NCT07505797 — ATUSA Ultrasound Diagnostic Imaging for Breast Lesions Evaluation (AUDIBLE) · recruiting
NCT07198724 — ERADICATE: A Phase Ib/II Study of Elacestrant Plus Trastuzumab Deruxtecan in Patients With CDK4/6 Inhibitor and Endocrin · Phase 1, PHASE2 · recruiting
NCT07331506 — Validation of the Oncoliq Test for the Early Detection of Breast Cancer. · recruiting
NCT07214883 — UCF MammoChat: Image Repository · recruiting
NCT07120100 — Transcranial Magnetic Stimulation for Chemotherapy-Induced Peripheral Neuropathy in Breast and Gynecologic Cancer Surviv · NA · recruiting

Other Changhua Christian Hospital trials

Trials by the same sponsor.

NCT07040215 — Effects on Subacute Stroke With Robotic Assistive Gait Training · NA · recruiting
NCT06970834 — Explore the Effect of Bitter Melon Peptides on Glycemic Control and Metabolic Indicators in Diabetic Patients · NA · not yet recruiting
NCT06432153 — Tampa Scale of Kinesiophobia for Heart Taiwan Version Validation · not yet recruiting
NCT06334237 — Psychosomatic Factors Influencing the Efficacy of Holistic Care for Migraine · recruiting
NCT06118294 — Efficacy of Probiotics for Parkinson Disease (PD) · NA · withdrawn

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04037852 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Changhua Christian Hospital
Last refreshed: 13 September 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04037852.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing